Baerveldt implant for secondary glaucoma due to iris melanoma
Annelie N Tan1, Juliette GMM Hoevenaars1, Carroll AB Webers1, Bertil Damato2, Henny JM Beckers11University Eye Clinic, Maastricht, The Netherlands; 2Ocular Oncology Service Royal Liverpool University Hospital, Liverpool, United KingdomBackground: Proton beam therapy (PBT) is effective in the treatme...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4d19a858410e4fb08a6a7ef0b3419a3b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4d19a858410e4fb08a6a7ef0b3419a3b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4d19a858410e4fb08a6a7ef0b3419a3b2021-12-02T07:42:13ZBaerveldt implant for secondary glaucoma due to iris melanoma1177-54671177-5483https://doaj.org/article/4d19a858410e4fb08a6a7ef0b3419a3b2010-05-01T00:00:00Zhttp://www.dovepress.com/baerveldt-implant-for-secondary-glaucoma-due-to-iris-melanoma-a4351https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Annelie N Tan1, Juliette GMM Hoevenaars1, Carroll AB Webers1, Bertil Damato2, Henny JM Beckers11University Eye Clinic, Maastricht, The Netherlands; 2Ocular Oncology Service Royal Liverpool University Hospital, Liverpool, United KingdomBackground: Proton beam therapy (PBT) is effective in the treatment of iris melanoma. Reported complications after PBT are radiation-induced cataract and raised intraocular pressure (IOP). Filtering glaucoma surgery has generally been avoided because of fears of seeding.Case report: A 37-year-old man presented with a self-discovered, pigmented lesion on his right iris. Four years later, the pigmented lesion was diagnosed as an iris melanoma, because of documented growth. The patient was treated with PBT but developed secondary glaucoma one month later. The IOP could not be controlled despite maximal medical therapy and selective laser trabeculoplasty (SLT). Finally, Baerveldt implant surgery was performed, resulting in an IOP lowering to 10 mmHg and stabilization of the glaucomatous visual field loss.Conclusion: Our case demonstrates that Baerveldt implant surgery is a reasonable therapy for glaucoma following successful radiotherapy of iris melanoma.Keywords: iris melanoma, proton beam therapy, secondary glaucoma, Baerveldt implant surgery Annelie N TanJuliette GMM HoevenaarsCarroll AB Weberset alDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2010, Iss default, Pp 407-409 (2010) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Ophthalmology RE1-994 |
spellingShingle |
Ophthalmology RE1-994 Annelie N Tan Juliette GMM Hoevenaars Carroll AB Webers et al Baerveldt implant for secondary glaucoma due to iris melanoma |
description |
Annelie N Tan1, Juliette GMM Hoevenaars1, Carroll AB Webers1, Bertil Damato2, Henny JM Beckers11University Eye Clinic, Maastricht, The Netherlands; 2Ocular Oncology Service Royal Liverpool University Hospital, Liverpool, United KingdomBackground: Proton beam therapy (PBT) is effective in the treatment of iris melanoma. Reported complications after PBT are radiation-induced cataract and raised intraocular pressure (IOP). Filtering glaucoma surgery has generally been avoided because of fears of seeding.Case report: A 37-year-old man presented with a self-discovered, pigmented lesion on his right iris. Four years later, the pigmented lesion was diagnosed as an iris melanoma, because of documented growth. The patient was treated with PBT but developed secondary glaucoma one month later. The IOP could not be controlled despite maximal medical therapy and selective laser trabeculoplasty (SLT). Finally, Baerveldt implant surgery was performed, resulting in an IOP lowering to 10 mmHg and stabilization of the glaucomatous visual field loss.Conclusion: Our case demonstrates that Baerveldt implant surgery is a reasonable therapy for glaucoma following successful radiotherapy of iris melanoma.Keywords: iris melanoma, proton beam therapy, secondary glaucoma, Baerveldt implant surgery |
format |
article |
author |
Annelie N Tan Juliette GMM Hoevenaars Carroll AB Webers et al |
author_facet |
Annelie N Tan Juliette GMM Hoevenaars Carroll AB Webers et al |
author_sort |
Annelie N Tan |
title |
Baerveldt implant for secondary glaucoma due to iris melanoma |
title_short |
Baerveldt implant for secondary glaucoma due to iris melanoma |
title_full |
Baerveldt implant for secondary glaucoma due to iris melanoma |
title_fullStr |
Baerveldt implant for secondary glaucoma due to iris melanoma |
title_full_unstemmed |
Baerveldt implant for secondary glaucoma due to iris melanoma |
title_sort |
baerveldt implant for secondary glaucoma due to iris melanoma |
publisher |
Dove Medical Press |
publishDate |
2010 |
url |
https://doaj.org/article/4d19a858410e4fb08a6a7ef0b3419a3b |
work_keys_str_mv |
AT annelientan baerveldtimplantforsecondaryglaucomaduetoirismelanoma AT juliettegmmhoevenaars baerveldtimplantforsecondaryglaucomaduetoirismelanoma AT carrollabwebers baerveldtimplantforsecondaryglaucomaduetoirismelanoma AT etal baerveldtimplantforsecondaryglaucomaduetoirismelanoma |
_version_ |
1718399222065135616 |